Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Chubb
Merck
Medtronic
Johnson and Johnson
Queensland Health
McKesson
Harvard Business School

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012772

« Back to Dashboard

NDA 012772 describes HALDRONE, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the HALDRONE profile page.

The generic ingredient in HALDRONE is paramethasone acetate. There are two drug master file entries for this compound. Additional details are available on the paramethasone acetate profile page.
Summary for 012772
Tradename:HALDRONE
Applicant:Lilly
Ingredient:paramethasone acetate
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 012772

Profile for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 012772

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-005 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HALDRONE paramethasone acetate TABLET;ORAL 012772-006 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Baxter
Dow
UBS
Harvard Business School
Argus Health
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.